Cargando…

Atrial fibrillation

Atrial fibrillation is the most common arrhythmia affecting patients today. Disease prevalence is increasing at an alarming rate worldwide, and is associated with often catastrophic and costly consequences, including heart failure, syncope, dementia, and stroke. Therapies including anticoagulants, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Munger, Thomas M., Wu, Li-Qun, Shen, Win K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Department of Journal of Biomedical Research 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904170/
https://www.ncbi.nlm.nih.gov/pubmed/24474959
http://dx.doi.org/10.7555/JBR.28.20130191
_version_ 1782301192922071040
author Munger, Thomas M.
Wu, Li-Qun
Shen, Win K.
author_facet Munger, Thomas M.
Wu, Li-Qun
Shen, Win K.
author_sort Munger, Thomas M.
collection PubMed
description Atrial fibrillation is the most common arrhythmia affecting patients today. Disease prevalence is increasing at an alarming rate worldwide, and is associated with often catastrophic and costly consequences, including heart failure, syncope, dementia, and stroke. Therapies including anticoagulants, anti-arrhythmic medications, devices, and non-pharmacologic procedures in the last 30 years have improved patients' functionality with the disease. Nonetheless, it remains imperative that further research into AF epidemiology, genetics, detection, and treatments continues to push forward rapidly as the worldwide population ages dramatically over the next 20 years.
format Online
Article
Text
id pubmed-3904170
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Editorial Department of Journal of Biomedical Research
record_format MEDLINE/PubMed
spelling pubmed-39041702014-01-28 Atrial fibrillation Munger, Thomas M. Wu, Li-Qun Shen, Win K. J Biomed Res Invited Review Atrial fibrillation is the most common arrhythmia affecting patients today. Disease prevalence is increasing at an alarming rate worldwide, and is associated with often catastrophic and costly consequences, including heart failure, syncope, dementia, and stroke. Therapies including anticoagulants, anti-arrhythmic medications, devices, and non-pharmacologic procedures in the last 30 years have improved patients' functionality with the disease. Nonetheless, it remains imperative that further research into AF epidemiology, genetics, detection, and treatments continues to push forward rapidly as the worldwide population ages dramatically over the next 20 years. Editorial Department of Journal of Biomedical Research 2014-01 2013-12-28 /pmc/articles/PMC3904170/ /pubmed/24474959 http://dx.doi.org/10.7555/JBR.28.20130191 Text en © 2014 by the Journal of Biomedical Research. All rights reserved.
spellingShingle Invited Review
Munger, Thomas M.
Wu, Li-Qun
Shen, Win K.
Atrial fibrillation
title Atrial fibrillation
title_full Atrial fibrillation
title_fullStr Atrial fibrillation
title_full_unstemmed Atrial fibrillation
title_short Atrial fibrillation
title_sort atrial fibrillation
topic Invited Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904170/
https://www.ncbi.nlm.nih.gov/pubmed/24474959
http://dx.doi.org/10.7555/JBR.28.20130191
work_keys_str_mv AT mungerthomasm atrialfibrillation
AT wuliqun atrialfibrillation
AT shenwink atrialfibrillation